BioAge Labs, Inc.

US$5.34As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BIOAHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (47.58%)
Div yield —
ROE (34.56%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.19
PE TTM —
TSR TTM (29.46%)
Mkt cap US$245.4M
ROIC (23.77%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.92
29.51%
(94.15%)
Hold 2|3|8|5|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.08
0.08
0.09
0.08
14.36%
13.00%
14.09%
5.69%
Revenue$M
12.91
13.68
14.15
13.99
1.85%
8.96%
11.10%
6.85%
Peers (US$245.4M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.041
—
—
EBIT/Intx
0.978
1.122
0.973
Own earn%
(124.74)
(81.34)
(88.30)
Sh yield%
31.47
60.78
57.96
Owners
Insiders/Inst%
6.06
46.09
Short interest%
1.29
SBC / revenue%
2.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–3
$1 testx
0.0
Incr. ROIC%
51